Advertise with us
[February 15, 2013]
MRI Interventions Announces Milestone Achievements
Feb 15, 2013 (M2 PRESSWIRE via COMTEX) -- MEMPHIS, Tenn., Feb 15, 2013 -- MRI Interventions, Inc. (OTCBB:MRIC) announced today that the company ended 2012 having achieved the 20 installation of its ClearPoint(R) Neuro Intervention System. ClearPoint systems are in clinical use with MRI scanners from the three major manufacturers, Siemens, GE Healthcare and Philips Healthcare, as well as the two major interventional MR/OR platforms that are manufactured by IMRIS and Brainlab.
MRI Interventions' innovative ClearPoint system is an integrated platform for performing a wide range of minimally-invasive neurological procedures under direct, real-time MRI guidance. ClearPoint is an integrated system of reusable components, disposable components and intuitive menu-driven software, which provides guidance for the placement and operation of instruments during neurological procedures performed within the MRI environment. Using the ClearPoint system, a surgeon sees and selects a neurological target, aims the ClearPoint SmartFrame(R) targeting device, and watches in real-time as the surgical instrument is advanced to the target.
As of December 31, 2012, ClearPoint systems have been installed at 20 sites worldwide. This includes 18 hospitals in the United States and two hospitals in Europe. In addition to the growth in its customer base, the company announced another milestone in having sold 200 disposable units of its SmartFrame kits in 2012. Depending on the type of neurological procedure being performed, a ClearPoint procedure will utilize either one or two SmartFrame kits. The SmartFrame targeting device is an MRI-compatible trajectory frame that serves as the centerpiece of the ClearPoint system's disposable components.
"We finished 2012 with significant business momentum, including the addition of two more prestigious institutions to our customer base, The Johns Hopkins University and the University of California, San Diego Health System. We are pleased to be associated with these clinical thought leaders. We are also pleased that we continue to see increased traction with significant growth in our disposable units sold," said Kimble Jenkins, CEO of MRI Interventions.
About MRI Interventions, Inc.
Founded in 1998, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Utilizing a hospital's existing MRI suite, the company's FDA-cleared ClearPoint(R) system is designed to enable a wide range of minimally invasive procedures in the brain. MRI Interventions has a co-development and co-distribution agreement with Brainlab, a leader in software-driven medical technology, relating to the ClearPoint system. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace(TM) system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation. Building on the imaging power of MRI, the company's interventional platforms strive to improve patient care while reducing procedure costs and times. MRI Interventions is also working with Boston Scientific Corporation to incorporate its MRI-safety technologies into Boston Scientific's implantable leads for cardiac and neurological applications. For more information, please visit www.MRIinterventions.com.
Read the full story and keep up with all the latest market news on TheStock411.com CONTACT: Info@thestock411.com ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at
on the world wide web. Inquiries to firstname.lastname@example.org.
Back To NFVZone's Homepage